Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target

Lung and breast cancer are the leading causes of mortality in women worldwide. The discovery of molecular alterations that underlie these two cancers and corresponding drugs has contributed to precision medicine. We found that CCND2 is a common target in lung and breast cancer. Hypermethylation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Chin-Sheng, Wang, Sheng-Chao, Yen, Yi-Ting, Lee, Tzong-Huei, Wen, Wu-Che, Lin, Ruo-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213171/
https://www.ncbi.nlm.nih.gov/pubmed/30308939
http://dx.doi.org/10.3390/ijms19103096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213171/
https://www.ncbi.nlm.nih.gov/pubmed/30308939
http://dx.doi.org/10.3390/ijms19103096

Ejemplares similares